Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma

NCT01009970 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Prednisone
DRUG: Doxorubicin

Sponsor

Fondazione Italiana Linfomi - ETS